CONSOLIDATED STATEMENT OF INCOME (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Revenues
Interest revenue	$ 62,970		$ 67,298		$ 71,858
Interest expense	16,177		20,612		24,209
Net interest revenue	46,793		46,686		47,649
Commissions and fees	13,113		12,732		12,665
Principal transactions	7,121		4,781		7,234
Administration and other fiduciary fees	4,089		4,012		3,995
Realized gains on sales of investments, net	748		3,251		1,997
Other-than-temporary impairment losses on investments
Gross impairment losses	(633)	[1]	(5,037)	[1]	(2,413)	[1]
Less: Impairments recognized in AOCI	98		66		159
Net impairment losses recognized in earnings	(535)		(4,971)		(2,254)
Insurance premiums	2,280		2,395		2,561
Other revenue	2,757	[2]	242	[2]	3,484	[2]
Total non-interest revenues	29,573		22,442		29,682
Total revenues, net of interest expense	76,366		69,128		77,331
Provisions for credit losses and for benefits and claims
Provision for loan losses	7,604		10,458		11,336
Policyholder benefits and claims	830		887		972
Provision (release) for unfunded lending commitments	80		(16)		51
Total provisions for credit losses and for benefits and claims	8,514		11,329		12,359
Operating expenses
Compensation and benefits	23,967		25,119		25,614
Premises and equipment	3,165		3,266		3,310
Technology/communication	6,136		5,829		5,055
Advertising and marketing	1,888		2,164		2,268
Other operating	13,199		13,596		14,003
Total operating expenses	48,355	[3]	49,974	[3]	50,250	[3]
Income (loss) from continuing operations before income taxes	19,497		7,825		14,722
Provision for income taxes	5,867		7		3,575
Income from continuing operations	13,630		7,818		11,147
Discontinued operations
Loss from discontinued operations	(242)		(109)		(75)
Gain (loss) on sale	268		(1)		155
Provision (benefit) for income taxes on discontinued operations	(244)		(52)		12
Income (loss) from discontinued operations, net of taxes	270		(58)		68
Net income before attribution of noncontrolling interests	13,900		7,760		11,215
Noncontrolling interests	227		219		148
Citigroup's net income	$ 13,673		$ 7,541		$ 11,067
Basic earnings per share
Income from continuing operations (in dollars per share)	$ 4.27	[4],[5]	$ 2.53	[4],[5]	$ 3.71	[4],[5]
Income (loss) from discontinued operations, net of taxes (in dollars per share)	$ 0.09	[4],[5]	$ (0.02)	[4],[5]	$ 0.02	[4],[5]
Net income (in dollars per share)	$ 4.35	[4],[5]	$ 2.51	[4],[5]	$ 3.73	[4],[5]
Weighted average common shares outstanding (in shares)	3,035.8		2,930.6		2,909.8
Diluted earnings per share
Income from continuing operations (in dollars per share)	$ 4.26	[4],[5]	$ 2.46	[4],[5]	$ 3.60	[4],[5]
Income (loss) from discontinued operations, net of taxes (in dollars per share)	$ 0.09	[4],[5]	$ (0.02)	[4],[5]	$ 0.02	[4],[5]
Net income (in dollars per share)	$ 4.35	[4],[5]	$ 2.44	[4],[5]	$ 3.63	[4],[5]
Adjusted weighted average common shares outstanding (in shares)	3,041.6	[4]	3,015.5	[4]	2,998.8	[4]

[1] 2012 includes the recognition of a $3,340 million impairment charge related to the carrying value of Citi's then-remaining 35% interest in the Morgan Stanley Smith Barney joint venture (MSSB), as well as the recognition of a $1,181 million impairment charge related to Citi's investment in Akbank. The remaining MSSB interest was sold during 2013. See Note 14 to the Consolidated Financial Statements.

[2] Other revenue for 2012 includes a $1,344 million loss related to the sale of a 14% interest in MSSB, as well as the recognition of a $424 million loss related to the sale of a 10.1% stake in Akbank T.A.S. See Note 14 to the Consolidated Financial Statements.

[3] Citigroup recorded repositioning charges of $590 million for 2013, $1,375 million for 2012 and $706 million for 2011.

[4] All per share amounts and Citigroup shares outstanding for all periods reflect Citigroup's 1-for-10 reverse stock split, which was effective May 6, 2011.

[5] Due to rounding, earnings per share on continuing operations and discontinued operations may not sum to earnings per share on net income.